Medacta Group SA operates primarily in the orthopedics sector, offering a comprehensive portfolio of implants and instruments for hip, knee, and shoulder replacements, as well as spine and sports medicine procedures. The company's business is structured around these key product lines, with joint reconstruction generating the majority of its revenue. Medacta focuses on medical education and specialized surgical approaches, notably its Anterior Minimally Invasive Surgery (AMIS) technique for hip replacements and its MySolutions personalized kinematic models. Headquartered in Castel San Pietro, Switzerland, the company manufactures its products domestically and distributes them internationally through direct subsidiaries and independent distributors. Its geographic footprint spans over 40 countries, with significant market shares in Europe, the United States, Japan, and Australia.
